4.7 Article

A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.ijbiomac.2016.07.026

Keywords

Phage; Fab; GluA4

Funding

  1. Lundbeck Foundation [R54-A5291]
  2. GluTarget Centre of Excellence at University of Copenhagen
  3. Drug Research Academy
  4. Novo Nordisk Foundation
  5. NIH [R01-GM113240, P20-GM113132]

Ask authors/readers for more resources

A method for development of murine Fab fragments towards extracellular domains of a surface receptor is presented. The GluA4 ionotropic glutamate receptor is used as a model system. Recombinant GluA4 ectodomain comprising both the N-terminal domain (NTD) and the ligand-binding domain (LBD) in one molecule was used for immunization. A Fab-phage library was constructed and a parallel panning approach enabled selection of murine Fab fragments towards either intact ectodomain or the isolated LBD of the GluA4 receptor. One LBD-Fab (FabL9) showed exclusive selectivity for the GIuA4 LBD, over a panel of LBDs from G1uA2, GluK1, GluK2 and GluD2. Soluble FabL9 was produced in amounts suitable for characterization. Competitive ELISA and rat-brain immunoprecipitation experiments confirmed that the FabL9 epitope is conserved in the LBD and in the intact native receptor. By an alignment of G1uA2 and GluA4, the likely binding epitope for FabL9 was predicted. This study demonstrates a simple approach for development of antibody fragments towards specific sub-domains of a large ligand-gated ion channel, and this method could be utilized for all multi-domain surface receptors where antibody domain-selectivity may be desirable. Furthermore, we present for the first time a GIuA4 subtype-specific murine Fab fragment targeting the LBD of the receptor. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available